Mounjaro vs altRx
Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey
Mounjaro vs altRx: Overview
Choosing between Mounjaro and altRx for GLP-1 weight loss medication? Both are popular providers, but they differ in pricing, medication options, and service features.
Mounjaro focuses on tirzepatide at $1080/month with a rating of 9.2/10. altRx also provides both semaglutide and tirzepatide at $149/month with a 6.5/10 rating.
The price difference of $931/month is significant - altRx is the more budget-friendly option, while Mounjaro positions itself as a premium service.
Our recommended brand
After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.
At a glance
Mounjaro
View full Mounjaro review →Pros
- ✓FDA-approved for type 2 diabetes
- ✓Weekly injection
- ✓Effective for weight loss (~15-20%)
- ✓Dual GIP/GLP-1 mechanism
- ✓Often covered by insurance for diabetes
Cons
- ✗Primarily approved for diabetes, not weight loss
- ✗Requires prescription
- ✗May cause nausea and digestive issues
- ✗Supply shortages reported
altRx
View full altRx review →Pros
- ✓Flat pricing across doses is promised in the banner: "SAME PRICE EVERY MONTH"
- ✓Promotional rates published up front - GLP-1 from $89/month and GLP-1 + GIP from $149/month
- ✓24/7 support advertised, and no insurance required
Cons
- ✗The FDA has formally told altRx that its labelling and its "clinically proven" claims misrepresented its compounded products - see the warning letter above
- ✗The medication is compounded and therefore not FDA-approved - the agency has not reviewed it for safety, effectiveness or manufacturing quality
- ✗Compounded GLP-1 pricing in this tier is cheap partly because the product carries none of the trial programme, patent or distribution costs of the approved drug - and none of its regulatory review either
- ✗The headline rates are a dated summer promotion ("OFFER ENDS AUGUST 5TH AT MIDNIGHT") against a standing price of $199/month, so the advertised figure is not the ongoing one
- ✗No phone number, refund policy or pharmacy named on the site
Feature-by-feature comparison
| Feature | Mounjaro | altRx |
|---|---|---|
| Monthly Price | $1080 | $149 |
| Rating | 9.2/10 | 6.5/10 |
| Medications | tirzepatide | semaglutide, tirzepatide |
| Insurance Accepted | Yes | No |
| Support Hours | Mon-Fri 8AM-8PM ET | Not published |
| Live Chat | No | No |
| Free Shipping | No | Yes |
| Shipping Speed | Varies by pharmacy | Not published |
| Mobile App | No | No |
| Dedicated Coach | Not included | Not included |
| Follow-up Frequency | As prescribed by physician | Not published |
| Money-back Guarantee | Savings card available ($25 per month for eligible patients) | None published |
| Cancellation Policy | Prescription-based, consult doctor | Not published |
Which should you choose?
Choose Mounjaro if you:
- →Prefer a higher-rated service (9.2/10 vs 6.5/10)
- →Need insurance coverage for your treatment
- →Value: fda-approved for type 2 diabetes
Choose altRx if you:
- →Want to save $931/month with a more affordable option
- →Want more medication options to choose from
- →Value: flat pricing across doses is promised in the banner: "same price every month"
Website previews
Mounjaro
altRx
